This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this podcast series. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular ...
The 6th WSPH Task Force on Hemodynamic Definitions and Clinical Classification recently proposed reducing the diagnostic mPAP threshold for pulmonary hypertension. After much debate among experts, ...
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Receive the the latest news, research, and presentations from major meetings ...
Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the ...
Pulmonary hypertension is characterized by increased BP in the pulmonary vasculature You will want your patients to consult a specialist to slow progression of this debilitating disease. Here's what ...
Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial ...
Individualized treatment and close monitoring are essential for pregnant women with pulmonary hypertension due to high maternal and fetal risks. Prognosis in pulmonary hypertension varies with ...
And of course, pulmonary arterial hypertension (PAH) itself is a rare disease. Ray, talk a little bit about the difference between PH and PAH in terms of definition. Benza: That's a really great thing ...
PAH is a disorder of vasoconstriction and proliferation, and treatment focuses on medications that act on or reverse these specific events. Conventional therapy consists of diuretics, oxygen, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results